{"schema_version":"1","generated_at":"2026-11-05T08:13:33.030Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nahal-lalefar","json_url":"https://www.findmykol.com/kol/nahal-lalefar/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nahal-lalefar","name":"Nahal Lalefar","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of California, San Francisco","institution_url":"https://www.findmykol.com/institution/university-of-california-san-francisco","city":"Oakland","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1548585748","orcid":"0000-0002-5651-7426","openalex":"A5083417959"},"summary":"Nahal Lalefar is an Oncology physician affiliated with University of California, San Francisco. OpenAlex indexes 45 publications with 591 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":45,"cited_by_count":591,"h_index":11,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":118.44,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1548585748"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1548585748","source":"payments"},"publications":{"total":45,"shown":5,"withheld":40,"matched_by":"OpenAlex author record","recent":[{"title":"Outcomes Following Graft Failure and Second Subsequent Allogeneic Hematopoietic Cell Transplant in Patients with Sickle Cell Disease: A Multicenter Study","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.033","status":"verified"},{"title":"High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2026.08.011","status":"verified"},{"title":"Optimal Thiotepa Exposure Is Associated with Improved Rejection and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta-T-cell/CD19-Depleted Haploidentical HCT for Hematologic Malignancy","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.859","status":"verified"},{"title":"Role of BM and PB Next Generation Sequencing (NGS) MRD Vs. BM Multichannel Flow Cytometry (MFC) MRD Pre/Post-Allogeneic HCT in Predicting Outcomes for Children and Young Adults (CAYA) with B-ALL: Planned Analysis of the Ptctc ONC1401 Trial","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.147","status":"verified"},{"title":"Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701)","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.144","status":"verified"}],"source":"works"},"contact":{"address_1":"747 52ND ST","city":"Oakland","state":"CA","zip":"946091809","phone":"510-428-3885","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1548585748","source":"identity"},"similar":[{"name":"Talmadge King","slug":"talmadge-king","institution":"University of California, San Francisco","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/talmadge-king","json_url":"https://www.findmykol.com/kol/talmadge-king/profile.json"},{"name":"Adil Daud","slug":"adil-daud","institution":"University of California, San Francisco","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/adil-daud","json_url":"https://www.findmykol.com/kol/adil-daud/profile.json"},{"name":"Emmanuelle Waubant","slug":"emmanuelle-waubant","institution":"University of California, San Francisco","specialty":"Neurology","url":"https://www.findmykol.com/kol/emmanuelle-waubant","json_url":"https://www.findmykol.com/kol/emmanuelle-waubant/profile.json"},{"name":"Peter Ganz","slug":"peter-ganz","institution":"University of California, San Francisco","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/peter-ganz","json_url":"https://www.findmykol.com/kol/peter-ganz/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":40}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-04-10","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}